COGNICURRENT

The EPA chief and Bayer CEO discussed litigation involving glyphosate weed killer before the Trump administration supported Bayer ahead of a Supreme Court case.

Donald Trump's recent executive order mandated the production of glyphosate, raising health concerns regarding its links to cancer while also prioritizing the production of military-grade phosphorus used in munitions.

Bayer is advancing in its legal disputes over glyphosate but still faces significant financial challenges from its acquisition of Monsanto.

Bayer announced significant losses of approximately 3.6 billion euros in 2025 due to litigation costs associated with glyphosate cancer risk lawsuits in the United States.

Bayer's ongoing legal battles over glyphosate continue to significantly impact the company's financial results, with losses projected to rise due to litigation costs.

Bayer has reported a significant loss due to ongoing litigation costs associated with glyphosate, amounting to 3.62 billion euros in 2025.

Bayer's CEO Bill Anderson is attempting to resolve the company's ongoing glyphosate litigation issues in the U.S., but challenges remain despite some support from political figures.

The debate surrounding glyphosate, a herbicide linked to health risks, intensifies following a controversial executive order from President Trump to ensure its availability for national defense.

Florida's Department of Health has raised alarms over elevated levels of arsenic and glyphosate found in widely consumed food products, including popular bread and candy brands.

Bayer is reportedly proposing a multi-billion dollar settlement to resolve ongoing lawsuits regarding cancer claims linked to its herbicide Roundup.

Robert F. Kennedy Jr. defends President Trump's executive order to protect glyphosate production, despite previously linking it to a chronic disease epidemic in America.

Donald Trump has signed an executive order aimed at protecting glyphosate-based herbicides, despite ongoing legal challenges linking them to health issues.

Bayer has reached a multi-billion dollar settlement related to glyphosate lawsuits, causing significant fluctuations in its stock prices.

Donald Trump's recent presidential decree classifies glyphosate-based herbicides as essential for U.S. national security, benefiting the pharmaceutical company Bayer.

US President Donald Trump has ordered an increase in the production of the controversial herbicide glyphosate, deeming it essential for the country’s food security.

The article discusses the United States' continued support for glyphosate and the Roundup brand, despite ongoing legal challenges related to health concerns.

President Trump has designated the controversial herbicide Glyphosate as essential for U.S. national security and food safety.

Donald Trump has announced support for increasing glyphosate production in the U.S., citing its importance for food security despite health concerns.

Bayer's recent multi-billion dollar settlement regarding glyphosate initially pleased investors, but skepticism soon led to a significant drop in stock prices.

Bayer faces ongoing challenges despite reaching a multibillion-dollar settlement regarding glyphosate lawsuits in the United States.

Bayer is negotiating a costly settlement related to glyphosate lawsuits in the USA to mitigate legal risks as it faces substantial financial losses.

Bayer has proposed a settlement of up to $7.25 billion to resolve around 65,000 lawsuits in the U.S. linking its herbicide Roundup to cancer.

Bayer, the German pharmaceutical company, faces a potential billion-dollar settlement regarding lawsuits tied to glyphosate, a weed killer linked to cancer claims.

Bayer has proposed a $7.25 billion settlement to resolve lawsuits alleging that its herbicide Roundup caused cancer.

Bayer has reached a multi-billion dollar settlement in the U.S. related to lawsuits over the herbicide Roundup, amounting to up to $7.25 billion over 21 years, pending court approval.

Bayer is on the verge of finalizing a settlement of up to $7.25 billion in the United States to resolve lawsuits related to the herbicide Roundup, pending court approval.

Corteva, a US chemical company, will cease production of Enlist Duo, a controversial herbicide criticized for its toxic components linked to health and environmental risks.

Residents of southern Lebanon express fears over Israeli aircraft spraying chemicals that may harm agricultural land and water supply.

Governor Ron DeSantis raised concerns over health risks after testing revealed high levels of glyphosate in various bread products during a press conference.

Beirut has accused Israel of spraying glyphosate on its side of the border amidst ongoing tensions.

Beirut has accused Israel of spraying glyphosate on the Lebanese side of the border, raising concerns from the UN about the long-term impacts on agriculture and the local population.

Testing has revealed the presence of the carcinogenic pesticide glyphosate in UK playgrounds, raising concerns about children's exposure as campaigners urge for a ban on its use in public spaces.

Bayer has been under pressure from glyphosate lawsuits for years, but recent recommendations to the Supreme Court and advancements in its pharmaceutical business could make 2026 a pivotal year for the company and its shareholders.

The European Commission's proposal for the indefinite approval of glyphosate reignites an ongoing controversy surrounding the herbicide and aims to reduce bureaucracy for farmers and producers.